0557195 - BTÚ 2022 RIV eng P - Patentový dokument
Hubáčková, Soňa - Werner, Lukáš - Štursa, Jan - Neužil, Jiří
Compounds for treatment of senescence-related disorders.
2018. Vlastník: Springtide Ventures s.r.o., Smart Brain s.r.o., Biotechnologicky ustav AV CR, v. v. i., MitoTAX s.r.o. Datum udělení patentu: 07.06.2018. Číslo patentu: AU2017368107
Institucionální podpora: RVO:86652036
Klíčová slova: Senescence * Mitochondria * Longevity
Obor OECD: Biochemistry and molecular biology
Web výsledku:
https://worldwide.espacenet.com/patent/search/family/057471690/publication/AU2017368107B2?q=pn%3DAU2017368107B2

The present invention relates to compounds of general formula (I) in particular for use in the treatment of senescence-related diseases, such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, prostatic hyperplasia.
Trvalý link: http://hdl.handle.net/11104/0331263